Cystic fibrosis and HPV: new study aims to protect Women's health

NCT ID NCT03052556

Completed Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at how common human papillomavirus (HPV) infection and abnormal cervical cells are in women with cystic fibrosis (CF). Researchers tested 85 women using Pap smears and HPV DNA tests. The goal was to understand infection rates and how long the virus lasts, so doctors can improve screening and encourage HPV vaccination for women with CF.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could lead to better cervical screening guidelines and greater awareness of HPV vaccination for women with cystic fibrosis.
What could go wrong: This is a small observational study (85 women) that only measures infection rates, not a treatment. Results may not apply to all women with cystic fibrosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cystic fibrosis Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYSTIC FIBROSIS

Contacts and locations

Locations

Service de Gynécologie oncologique - Centre Hospitalier Lyon Sud

Pierre-Bénite, France, 69310, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.